Other types of follicular lymphoma
ICD-10 C82.8 is a billable code used to indicate a diagnosis of other types of follicular lymphoma.
Follicular lymphoma is a type of non-Hodgkin lymphoma characterized by the proliferation of follicle center (germinal center) B-cells. C82.8 encompasses various subtypes of follicular lymphoma that do not fit into the more commonly recognized categories, such as follicular lymphoma grade 1, 2, or 3. These subtypes may exhibit unique histological features, clinical behaviors, and responses to treatment. Patients may present with lymphadenopathy, splenomegaly, or extranodal involvement. The disease is typically indolent but can transform into a more aggressive form. Staging is crucial and follows the Ann Arbor classification, which assesses the extent of lymph node involvement and any extranodal disease. B-symptoms, including fever, night sweats, and weight loss, may be present and are indicative of more advanced disease. Treatment protocols often involve watchful waiting for asymptomatic patients, while symptomatic cases may require chemotherapy, immunotherapy, or targeted therapies. The choice of treatment is influenced by the specific subtype, stage, and patient factors.
Detailed pathology reports, staging information, and treatment plans.
Diagnosis of follicular lymphoma, treatment planning, and management of complications.
Ensure accurate documentation of subtype and staging to support coding.
Comprehensive histological reports and immunophenotyping results.
Biopsy interpretation and classification of lymphoma subtypes.
Clear communication of findings to support accurate coding.
Used to monitor blood counts during treatment.
Document the reason for the CBC and any abnormalities noted.
Hematology specialists should ensure accurate interpretation of results.
Treatment for C82.8 may include watchful waiting, chemotherapy, immunotherapy, or targeted therapies, depending on the specific subtype and stage of the disease.